Table 3.
Comparison of 5 year clinical outcomes between the three phenogroups in the derivation cohort
| 5 year clinical outcome | Phenogroup 1 (n = 119) | Phenogroup 2 (n = 184) | Phenogroup 3 (n = 39) | P value |
|---|---|---|---|---|
| Primary endpoint, n (%) | 90 (72.0) | 117 (58.5) | 18 (45) | 0.0036 |
| Secondary endpoint | ||||
| All‐cause death, n (%) | 62 (51.7) | 88 (44.0) | 8 (20) | 0.0021 |
| Cardiovascular death, n (%) | 35 (28.0) | 39 (19.5) | 5 (12.5) | 0.0467 |
| Heart failure re‐hospitalization, n (%) | 53 (42.4) | 51 (25.5) | 12 (30.0) | 0.0061 |
Primary endpoint included all‐cause death and heart failure re‐hospitalization.